Fate Therapeutics, Inc. (FATE)
1.13
-0.03
(-2.59%)
USD |
NASDAQ |
Mar 17, 16:00
1.17
+0.04
(+3.54%)
After-Hours: 19:23
Fate Therapeutics Total Liabilities (Quarterly) : 111.75M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| MannKind Corp. | 843.20M |
| Vertex Pharmaceuticals, Inc. | 7.477B |
| Ardelyx, Inc. | 335.86M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 318.94M |
| Shareholders Equity (Quarterly) | 207.18M |
| Debt to Equity Ratio | 0.3757 |
| Current Ratio | 5.786 |
| Net Debt Paydown Yield | 3.73% |